Affirma Biotech is a company headquartered in Spain. Its most recent tracked round is Seed.
Affirma Biotech develops new orally available immunostimulatory drugs to treat severe respiratory infections, focusing on enhancing immune response in hospitalized patients with diseases like influenza and community-acquired pneumonia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.